PD-1/PD-L1 activation can decrease the antitumor activity of tumor infiltrating lymphocytes (TILs) by inducing apoptosis, inhibiting the production of granular enzyme/perforin, and decreasing the secretion of IFN-γ/IL-2/TNF-α 19. The gene discussed is TNF; the disease is neoplasm.